278 related articles for article (PubMed ID: 23741300)
1. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.
Wang YY; Zhang CY; Ma YQ; He ZX; Zhe H; Zhou SF
Drug Des Devel Ther; 2015; 9():3163-78. PubMed ID: 26124639
[TBL] [Abstract][Full Text] [Related]
3. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.
Tran TA; McCoy MK; Sporn MB; Tansey MG
J Neuroinflammation; 2008 May; 5():14. PubMed ID: 18474101
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Guo ZZ; Sun HY; Hu DC; Yang GH; Li YM; Wei LQ
PLoS One; 2013; 8(11):e81090. PubMed ID: 24260540
[TBL] [Abstract][Full Text] [Related]
5. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation.
Iyer SN; Hyde DM; Giri SN
Inflammation; 2000 Oct; 24(5):477-91. PubMed ID: 10921510
[TBL] [Abstract][Full Text] [Related]
7. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
Hagiwara SI; Ishii Y; Kitamura S
Am J Respir Crit Care Med; 2000 Jul; 162(1):225-31. PubMed ID: 10903246
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Psgl-1 accelerates bleomycin (BLM)-induced lung fibrosis and inflammation in mice through activating PI3K/AKT.
Han X; Wang SM
Biochem Biophys Res Commun; 2017 Sep; 491(2):558-565. PubMed ID: 28263743
[TBL] [Abstract][Full Text] [Related]
10. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
11. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
[TBL] [Abstract][Full Text] [Related]
12. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
13. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
[TBL] [Abstract][Full Text] [Related]
14. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
15. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
[TBL] [Abstract][Full Text] [Related]
16. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
Nie Y; Yu K; Li B; Hu Y; Zhang H; Xin R; Xiong Y; Zhao P; Chai G
J Pharmacol Sci; 2019 Apr; 139(4):377-384. PubMed ID: 30928090
[TBL] [Abstract][Full Text] [Related]
17. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
[TBL] [Abstract][Full Text] [Related]
18. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
19. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis.
Driscoll KE; Maurer JK; Higgins J; Poynter J
J Toxicol Environ Health; 1995 Oct; 46(2):155-69. PubMed ID: 7563215
[TBL] [Abstract][Full Text] [Related]
20. NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis.
Liu CP; Kuo MS; Wu BN; Chai CY; Huang HT; Chung PW; Chen IJ
Pulm Pharmacol Ther; 2014 Feb; 27(1):17-28. PubMed ID: 23518214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
